1. 10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016. Issue 9 (September 2018) Authors: Endrikat, Jan; Dohanish, Susan; Schleyer, Nicolas; Schwenke, Susanne; Agarwal, Sheela; Balzer, Thomas Journal: Investigative radiology Issue: Volume 53:Issue 9(2018:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gadobutrol in Renally Impaired Patients: Results of the GRIP Study. Issue 1 (January 2017) Authors: Michaely, Henrik J.; Aschauer, Manuela; Deutschmann, Hannes; Bongartz, Georg; Gutberlet, Matthias; Woitek, Ramona; Ertl-Wagner, Birgit; Kucharczyk, Walter; Hammerstingl, Renate; De Cobelli, Francesco; Rosenberg, Martin; Balzer, Thomas; Endrikat, Jan Journal: Investigative radiology Issue: Volume 52:Issue 1(2017:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications. Issue 9 (September 2016) Authors: Endrikat, Jan; Vogtlaender, Kai; Dohanish, Susan; Balzer, Thomas; Breuer, Josy Journal: Investigative radiology Issue: Volume 51:Issue 9(2016:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety of gadoxetate disodium: Results from the clinical phase II–III development program and postmarketing surveillance. Issue 3 (2nd February 2015) Authors: Endrikat, Jan S.; Dohanish, Susan; Balzer, Thomas; Breuer, Josy A.M. Journal: Journal of magnetic resonance imaging Issue: Volume 42:Issue 3(2015) Page Start: 634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗